Organization | Fu Jen Catholic University

Fu Jen Catholic University Report issue

Academic/Hospital Phase 4

Founded: New Taipei City Taiwan (1925)

Organization Overview

First Clinical Trial

2008

NCT01019668

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Alternative names

Fu Jen Catholic University | Fu-Jen Catholic University, Department of Nutritional Science | Fu Jen Catholic University Hospital | Shin-Kong Wu Ho-Su Memorial Hospital, School of Medicine, Fu-Jen Catholic University

Active Ingredients

Drugs in Phase 4 Trials (4)

amoxicillin (1 trial)

clarithromycin (biaxin) (1 trial)

tenofovir (viread) (2 trials)

vonoprazan (Voquezna) (1 trial)

Drugs in Other Trials (9)

celery (1 trial)

choline (1 trial)

dried purple laver (1 trial)

verteporfin (visudyne) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 13